Treatment of Wounds With a New Adhesive Foam Dressing
- Conditions
- Wounds and InjuriesBurns
- Interventions
- Device: ELECT
- Registration Number
- NCT02807584
- Lead Sponsor
- Smith & Nephew, Inc.
- Brief Summary
This study will look at whether ELECT, a new adhesive foam dressing, can offer an alternative to traditional wound care methods.
Patients will be treated with ELECT for 14 days. Data relating to wound healing, the performance of the dressing and the opinion of the doctor will be collected.
The hypothesis of this study is that the ELECT foam adhesive dressing is 'fit for purpose' and will be effective at treating a variety of wounds.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 25
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description ELECT ELECT Adhesive Foam Dressing
- Primary Outcome Measures
Name Time Method Wound progression, (percentage change in area) using a wound imaging measurement and wound documentation system 14 days using a wound imaging, measurement and wound documentation system
- Secondary Outcome Measures
Name Time Method Reason for dressing change 14 days Duration of dressing wear 14 days Assessment of exudate type and amount 14 days Assessment using a modified Bates-Jensen Would Assessment Tool1 and T.I.M.E.2,3)
Pain on application and removal of dressing (using a Visual Analogue Scale (VAS) or FLACC scale) 14 days Percentage change in wound depth 14 days The proportion of wounds that have 100% healed or closed by secondary intention. 14 days Ease of application and removal of the ELECT dressing using the visual analogue scale 14 days Clinician acceptability with dressing performance parameters 14 days Measured using a questionnaire
Percentage change in wound volume 14 days Assessment of Condition of the peri-wound skin 14 days Assessment using a modified Bates-Jensen Would Assessment Tool1 and T.I.M.E.2,3)
Assessment of the amount of tissue and skin colour 14 days Assessment using a modified Bates-Jensen Would Assessment Tool1 and T.I.M.E.2,3)
Assessment of infection/clinical signs of infection 14 days Assessment using Normal Clinical practice
Overall clinician acceptability with the new dressing 14 days Measured using a questionnaire
Safety in use - all adverse events that occur during the study will be recorded 14 days
Trial Locations
- Locations (1)
Inkosi Albert Luthuli Central Hospital (IALCH)
🇿🇦Durban, South Africa